Enterprise Solutions for Revenue Cycle Optimization. November 2016

Transcription

1 Enterprise Solutions for Revenue Cycle Optimization November 2016

2 Quality is the New Revenue The Looking Glass platform supports revenue cycle optimization for healthcare enterprises. Our integrated solutions, technology-enabled services and analytics enable providers to secure accurate reimbursement in a value-based world. 2

3 The Reality of Provider Financial Performance Margin Pressures Internal Challenges» Bad Debt/Cost to Collect» Denials/Underpayments» Days Not Final Billed (DNFB)» Coding Accuracy/Revenue Integrity External Challenges» Recovery Audit Contractor (RAC) Audits» Medicare Admin Contractor (MAC) Audits» Affordable Care Act (ACA) Penalties & New Uncertainty post Election» New Payment Models 3

4 Streamline Health Delivers Revenue Cycle Optimization Minimize Revenue Attrition Work Smarter, Get Paid Faster Looking Glass AR Management Looking Glass Denials Management Looking Glass Business Analytics Secure Your Money Looking Glass Audit Management Looking Glass Clinical Analytics Looking Glass Coding Audit Services & Coding Technology Solutions 4

5 Streamline Health Delivers Revenue Cycle Optimization Capture More Revenue» Looking Glass CDI» Looking Glass Coding Audit Services» Looking Glass CORE and evaluator» Looking Glass Clinical Analytics 5

6 Integrated Revenue Cycle Optimization If No, release to Billing HIM Looking Glass CDI Requires Audit? Looking Glass evaluator Automated pre-bill auditing for all charts Looking Glass Abstracting If Yes, send to Looking Glass CORE with narrative on recommended corrections Looking Glass CAC Looking Glass Enterprise Content Management Looking Glass CORE Audits Coding Changes? If Yes, send back for DRG review If No, release to Billing Billing Looking Glass AR Management Looking Glass Denials Management Looking Glass Audit Management Looking Glass Business Analytics 6

7 Streamline Health: Scope 7

8 World Class Client Base 8

9 The Reality of Provider Financial Performance Revenue Cycle Optimization Process Optimization Access Optimization Value-Based Care & Quality Initiatives Enterprise Performance Analytics 9

10 Competitive Landscape Revenue Cycle Optimization Process Optimization Access Optimization Value-Based Care & Quality Initiatives Enterprise Performance Analytics 10

11 Financial Performance Highlights Quarterly Revenue $9 Recurring Revenue Non-Recurring Revenue $(MM) + Q revenues $7.4M; +10% over Q H 2016 Adj. EBITDA $2.2M; +$1.6M improvement over 1H Q Cash balance $6.5M; even with Q Q Debt outstanding $6.2M, -$1.9M over Q Q Ending Backlog $53.6M $6 $3 -- $2 $1 Q Q Q Q Q Q Q Q Q EBITDA & EBITDA Margin Adj. EBITDA EBITDA Margin $(MM) 30% 15% -- (15%) -- Q Q Q Q Q (30%) 11

12 Company Summary Streamline Health supports revenue cycle optimization for healthcare enterprises. Our integrated solutions, technology-enabled services and analytics enable providers to drive more timely reimbursements in a value-based world. Exchange Ticker: Share Price (52 Week Range): NASDAQ: STRM Nov 9, 2016: $1.79 (52 Week High $2.11, Low - $1.08) Common Shares Outstanding: 19.7 million Market Cap: Nov 9, 2016: $35.3 million Cash: $6.5 million (July 31, 2016) Bank Debt: $6.2 million (July 31, 2016) Number of Associates:

13 Revenue Trading Comps 8.0x 7.0x 6.8x 6.9x 6.0x 5.0x 4.0x 3.0x 2.0x 1.0x 3.7x 3.7x 3.5x 3.5x 3.1x 3.1x 2.4x 2.3x 2.1x 1.9x CY 16 Median = 2.7x CY 17 Median = 2.7x 1.6x 1.7x 1.2x 1.2x -- MDSO ATHN CERN HSTM ABCO MDRX QSII STRM EV / CY16 Revenue EV / CY17 Revenue Key: MDSO: Medidata Solutions, Inc.; ATHN: athenahealth, Inc.; CERN: Cerner Corporation; HSTM: Healhstream Inc.; ABCO: The Advisory Board Company; MDRX: Allscripts Healthcare Solutions, Inc.; QSII: Quality Systems Inc.; STRM: Streamline Health Solutions, Inc. Source: CY 16 and CY 17 estimates for comparable companies from Craig-Hallum report dated Equity prices as of 11/9 from Yahoo Finance. Streamline estimates based on management guidance. Note: Enterprise value defined as Market Capitalization plus Net Debt. 13

14 Disclosure Statement SAFE HARBOR STATEMENT: FORWARD-LOOKING DISCLOSURE This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, based on current management expectations. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and that can cause Streamline Health s actual results to differ. We caution you therefore to not place undue reliance on such statements. Actual results might differ materially from these statements due to a number of risks and uncertainties. Risks that may contribute to the uncertain nature of these statements are described in Streamline Health s periodic filings made with Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled Risk Factors and Management s Discussion and Analysis of Financial Condition and Results of Operations. Streamline Health undertakes no obligation to update any forward-looking statements or relevant risks, except as may be required by law. TRADEMARKS Product or company names referenced herein may be trademarks or registered trademarks of their respective owners 14